About Us

At Reminova we are passionate about preventative dentistry and improving oral healthcare. It is in our Company DNA, as Reminova was started by dentists who have spent their whole working lives reducing the effects of dental caries through public health education, technology innovation, and widening the global understanding of dental caries disease progression.

Reminova was formed in 2014 to provide dentists and patients with new preventative treatments for tooth caries. Some years ago, our Company founder’s took a radically different approach to caries management that focused on repairing enamel and reversing decay, painlessly and quickly. Working collaboratively over many years with the best UK academics picked from the fields of dentistry, chemistry, engineering and imaging we got it to work, and we patented it too.  Our goal now is to see the dental instruments and treatment developed by Reminova to become the number one choice for repairing dental caries globally. We believe the technology and products can be used in many areas of dentistry to provide patients with better, safer treatments and outcomes including professional tooth whitening.

We are building a world class oral health company, headquartered in Scotland, focused on achieving our goals and delivering innovative solutions that support dentist’s and hygenist’s globally, and make it easier for people everywhere to keep their natural teeth for the whole of their lifetime.

You are invited join us on this mission as a shareholder in our Company. Be part of making drill-and-fill dentistry history. Please visit our equity crowd-funding page for more information on how you can become a shareholder in Reminova, be part of this mission and benefit from or future success. 

Board of Directors

Nigel Pitts
Chairman
Co-founder

Prof. Nigel Pitts BDS, PhD, FDS (RCS Eng), FDS (RCS Edin), FFGDP (UK), FFPH, FRSE

Chairman & Co-Founder

Nigel graduated in Dentistry at the University of London and, after spells at Universities in Hong Kong and Dundee (where he was Dental Dean), returned to join King’s College London in January 2013 to set up the Dental Innovation and Translation Centre.

He has achieved international recognition and numerous prizes for achievements in science, education, clinical practice, technology transfer and public health. Nigel has over 200 peer reviewed publications, over 90 publications in other forms and holds a wide range of professional Fellowships. Currently he is Co-Chair of the International Caries Detection and Assessment System (ICDAS) Foundation and also Chair and co-founder of the Alliance for a Cavity Free Future, an advocacy charity.

Nigel is an honorary Consultant in Dental Public Health within the UK’s National Health Service and also works with a wide number of research and professional organisations, private companies and global brands in oral healthcare in translating research evidence into both practice and policy. 

Chris Longbottom
Chief Scientist
Co-founder

Dr. Chris Longbottom

Chief Scientific Officer and Co-Founder

Chris has a long track record of pioneering new technology in the field of detection, diagnosis and treatment of dental caries, and has been a co-founder of two start-up companies previously. Chris has overall responsibility for Reminova’s technical programmes, and has a daily involvement in our development activities.

Chris was a General Dental Practitioner for over 15 years before his desire to have a more direct and longer-term impact in oral healthcare drove him to complete his PhD in Cariology in 1992, whilst lecturing in Preventive & Children's Dentistry at Dundee Dental School, and being a Research Fellow in the Dental Health Services Research Unit.

He has authored over 40 papers, several book chapters on dental caries and has collaborated widely with high growth start-up companies, Universities, and global oral healthcare companies. He is a named inventor on patents related to dental applications of bio-photonics, electro-chemistry, ultrasonics and imaging technologies. In recognition of his technology innovation, he was appointed as Assistant Director of the Dental Innovation & Translation Centre of King College London in 2013.

Jeff Wright
CEO
Exec. Director

Dr. Jeff Wright

CEO

Jeff has been a co-founder or Executive Leader of several early-stage technology companies over the last two decades. He took his 1st company, MicroEmissive Displays, from University spin-out to IPO in just over five years, raising over $15M of investment and collecting numerous entrepreneurial, technology and product awards en-route.

He has worked across a variety of industry sectors, developing and taking to market innovative products for consumer electronics, industrial & medical sensing and energy efficiency. As co-founder and CEO of Pyreos; a spin-out from German giant Siemens; he secured international investment from Europe and Japan alongside Scottish and UK investors, and personally closed out ~75% of the Company’s first $3 M of sales.

Jeff has a broad technical knowledge combined with a varied and wide business experience having at previous times held CTO and COO responsibilities. Jeff is a firm believer that everything is possible with belief and passion, investment only accelerates things along.  

Van Thompson
Non Exec. Director
Kings College

Prof. Van P Thompson

Non-Executive Director

Van is currently Professor of Tissue Engineering and Biophotonics, at King’s College London Dental Institute. Known for his work on adhesion and bonded bridges at the University of Maryland and later for work on ceramic fatigue at New York University, he has published many articles and made numerous presentations on dental biomaterials at international conferences.

Van has extensive links with the US dental industry and has previously developed innovative products that have become standard tools in dental practices.

His current research areas include diagnosing dentin caries activity, all-ceramic crown fatigue and fracture, engineering tissue response via scaffold architecture and practice based research (PEARL Network). 

Steve Howell
Non Exec. Director
Innova Partnerships

Dr. Steve Howell

Non-Executive Director

Steve is a serial entrepreneur and founder of Innova Partnerships Ltd. Innova works with entrepreneurs, universities and institutes to build their business opportunities into high growth life science companies.  He previously held senior management roles at Unilever plc and Alere Inc.

Steve has a broad knowledge of the Life Science sector and experience from R & D commercialisation to corporate acquisition. Both the Scottish and Irish governments have sought out Steve’s strategic thinking and advice in developing Life Science strategy and investment.

He has a passion for helping grow successful, profitable Life Science businesses. Innova Partnerships is an early stage investor and shareholder in Reminova.  

Management Team

Alistair Dobbie
Finance

Alistair Dobbie

Chief Financial Officer

Alistair brings a wealth of experience to his role as Reminova’s part-time CFO. He qualified as a chartered accountant in 1983 whilst at Coopers & Lybrand (now PWC), and worked for them in both the UK and Hong Kong.

For the last 25 years he has ran his own business providing financial advice and hands-on assistance to many of Scotland’s high growth businesses, developing their financial systems and controls and providing solid financial planning.

He has extensive investment experience having worked with several venture capital companies, and the Scottish government’s enterprise agency. 

Niall McLaren
Operations

Dr Niall McLaren

Chief Operating Officer

Niall has over a decade of experience managing, and delivering multi-million dollar development projects, and developing world class supply solutions. He has coordinated multi-party/multi-site clinical and pre-clinical developments for global pharmaceutical customers during his time at Catalent Pharma Solutions.

Niall graduated with a 1st class honours degree with distinction from Heriot-Watt University, before completing his PhD in Molecular Biology in 2003. Niall was awarded a prestigious Saltire Fellowship in 2014 which took him to Babson College, the number 1 ranked business school in USA. He combines his operational and technical knowledge with a passion for entrepreneurship and innovation.  

Edwin Lindsay
Regulatory

Edwin Lindsay

Director of Regulatory Affairs

Edwin is responsible for all aspects of the quality and regulatory systems within Reminova. He has an in-depth knowledge of developing and implementing quality, validation and regulatory systems for high growth companies.

His expertise was amassed over 20 years preparing and executing new and amended submissions for class 1,2 and 3 medical devices for both US FDA Regulatory (510K, PMA, IDE) and European (CE Marking) and ensuring compliance with  ISO 9001, ISO 13485, GMP/GLP and US FDA Quality system regulations. Edwin has previously held leadership positions at Smith & Nephew Ltd, Ethicon Ltd, AorTech Europe Ltd, and Compliance Solutions (Life Sciences) Ltd whilst consulting to many more. 

Joe Crayston
Technology

Dr Joe Crayston

Senior Scientist

Joe is one of the inventors of Reminova’s revolutionary EAER technology. As a long-time collaborator of Nigel and Chris, Joe brought his expert knowledge of electrochemistry to develop the methodology for rapid remineralization in tooth enamel.

He is involved in both research and development at Reminova. During his distinguished academic career; mainly at St Andrews University’s School of Chemistry, he published over 80 papers and review articles. He has worked extensively with industry and academic partners on a wide range of research projects, managing and delivering novel electrochemical solutions to solve complex problems for project sponsors.